[The shock-syndrome: aspects of coagulation and fibrinolytic therapy (author's transl)].
D001777:Blood Coagulation; D002648:Child; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006463:Hemolytic-Uremic Syndrome / Q000150:complications; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010958:Plasminogen; D012127:Respiratory Distress Syndrome, Newborn / Q000150:complications; D012771:Shock, Hemorrhagic / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D013300:Streptokinase / Q000627:therapeutic use; D014884:Waterhouse-Friderichsen Syndrome / Q000150:complications
D005343:Fibrinolytic Agents; D010958:Plasminogen; D013300:Streptokinase
Gerinnungsphysiologische Aspekte und Fibrinolytische Therapie des Schocks.